Research News

Marsha Ritter Jones, MD, PhD, was awarded a Mentored Research Training Grant from the Foundation for Anesthesia Education and Research for her project “The Role of Neuronal-Derived MD-1 in Cutaneous Inflammation.”

A research team in the laboratory of Bradley K. Taylor, PhD, uncovered a promising future therapeutic strategy to treat neuropathic pain.

Two studies investigating the role that auriculotherapy (a form of acupuncture applied to points on the ear) may play as an alternative to opioids for the postoperative management of pain by Jacques E. Chelly, MD, PhD, MBA, and colleagues were recently featured in Anesthesiology News.

The Foundation for Anesthesia Education and Research created the Medical Student Anesthesia Research Fellowship program to encourage talented medical students to consider careers in anesthesiology research and perioperative medicine.

The authors from our department were Grace Lim, MD, MS, (first author) and Anne Wanaselja, MD, an alum of our Obstetric Anesthesiology Fellowship Program.

As of October 2022, our portfolio of active grant support included over $48 million from the NIH.

Dr. Chauhan’s BIONIC team project won a $25,000 award in the virtual Elevator Pitch Competition and Dr. Emerick’s Vanish project won a $100,000 award as well as a $15,000 Bonus Award for Engineering Good Health.

Bradley K. Taylor, PhD; Abigail Hellman, PhD; Tyler Nelson; Aman Mahajan, MD, PhD, MBA; and Kimberly Howard-Quijano, MD, MS, FASE, were awarded $50,000 for their project “A Non-Invasive Nasal Spray to Treat Neuropathic Pain.”

Congratulations to principal investigators Sean P. Farris, PhD, and Gregg E. Homanics, PhD, who will receive U01 funding from the National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism for the project “Epigenetic Regulation of Neuroimmune Pathways.”

Siamak Salavatian, PhD, will present the poster “Spinal Cord Stimulation Mitigates the Myocardial Ischemia Induced Sympathoexcitation by Suppressing the Spinal Neural Synchrony and Intermediolateral Nucleus Hyperactivity” at the Experimental Biology annual meeting in Philadelphia, PA on April 4.